Julia E. Head

Integration of signal transduction inhibitors with endocrine therapy: an approach to overcoming hormone resistance in breast cancer.

Stephen Johnston, Julia E. Head, Sunil Pancholi et al. · PubMed · 2003 · 137 citations

Life Sciences, Endocrinology, Oncology +17

The farnesyltransferase inhibitor R115777 (tipifarnib) in combination with tamoxifen acts synergistically to inhibit MCF-7 breast cancer cell proliferation and cell cycle progression <i>in vitro</i> and <i>in vivo</i>

Lesley‐Ann Martin, Julia E. Head, Sunil Pancholi et al. · Molecular Cancer Therapeutics · 2007 · 47 citations · Full text

Medicine, Oncology, Pharmacology +17

Serum total hCGβ level is an independent prognostic factor in transitional cell carcinoma of the urothelial tract

James J. Douglas, Adam Sharp, Caroline Chau et al. · British Journal of Cancer · 2014 · 35 citations · Full text

Medicine, Oncology, Pathology +7